Metraipolis › archive › dc_1fac8610d85e

Efficacy and Safety of Anti-CD38 Antibody-Containing Triplet Regimens in Frail Patients with Multiple Myeloma — Europe PMC PMID:41976271

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41976271
DOI
10.3390/cancers18071048
License (as archived)
solo-consultazione
Archived
2026-11-03T23:38:30.249Z
SHA-256 of the archived text
50e7196e9a9b4a9f3c83175e6fb1f8987ba25238cffdeb13475fba7a5d1be3b7
Stable URL of this page
https://metraipolis.com/documento/dc_1fac8610d85e

How to cite

Efficacy and Safety of Anti-CD38 Antibody-Containing Triplet Regimens in Frail Patients with Multiple Myeloma — Europe PMC PMID:41976271 — Europe PMC (en), https://europepmc.org/article/MED/41976271 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1fac8610d85e (Metraipolis archive dc_1fac8610d85e, sha256 50e7196e9a9b4a9f3c83175e6fb1f8987ba25238cffdeb13475fba7a5d1be3b7)
BibTeX
@misc{dc1fac8610d85e,
  title = {Efficacy and Safety of Anti-CD38 Antibody-Containing Triplet Regimens in Frail Patients with Multiple Myeloma — Europe PMC PMID:41976271},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41976271},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1fac8610d85e; sha256 50e7196e9a9b4a9f3c83175e6fb1f8987ba25238cffdeb13475fba7a5d1be3b7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41976271. Agents can read the archived copy with the MCP tool read_document.